# Tedor Pharma, Inc. – FDA Inspection, Jan 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/9b5aa688-b7e6-4e1c-8397-a3e9cf008050
Source feed: FDA_Inspections

> FDA inspection 1077786 of Tedor Pharma, Inc., January 31, 2019. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077786
- Company Name: Tedor Pharma, Inc.
- Inspection Date: 2019-01-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1271887 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/d130b166-4fa4-417a-9823-05222a5913f9)
- [FDA Inspection 1010372 - 2017-04-20](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/6d50ae4a-31d4-4a0a-a156-4831edc01911)
- FDA Inspection 853221 - 2013-10-29
- FDA Inspection 743987 - 2011-09-09

## Related Officers

- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c